Hikma Pharmaceuticals PLC ADS (HKMPY) Financials N
Post# of 250675
Posted On: 11/17/2014 2:42:23 AM
Hikma Pharmaceuticals PLC ADS (HKMPY) Financials Nov 3, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Hikma Pharmaceuticals PLC ADS
Fiscal year is January-December. All values GBP millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 408.11M 473.43M 572.67M 699.69M 873.27M
Cost of Goods Sold (COGS) incl. D&A 212.89M 241.98M 324.94M 383.45M 384.49M
COGS excluding D&A 191M 217.08M 295.62M 346.6M 342.91M
Depreciation & Amortization Expense 21.88M 24.89M 29.32M 36.85M 41.58M
Depreciation 16.15M 18.84M 22.24M 26.73M 30.07M
Amortization of Intangibles 5.73M 6.05M 7.08M 10.12M 11.52M
Gross Income 195.22M 231.45M 247.72M 316.24M 488.77M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 116.37M 134.29M 154.51M 187.4M 218.8M
Research & Development 10.79M 15.29M 19.47M 21.47M 19.83M
Other SG&A 105.58M 119M 135.03M 165.93M 198.96M
Other Operating Expense 11.91M 15.13M 12.84M 17.32M 21.11M
Unusual Expense 0 342,633 11.31M 9.08M 39.66M
EBIT after Unusual Expense 0 (342,633) (11.31M) (9.08M) (39.66M)
Non Operating Income/Expense 1.68M 309,601 (1.48M) (6.61M) (3.84M)
Non-Operating Interest Income 329,367 224,104 291,940 798,946 1.28M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 8.22M 3.86M 8.58M 13.87M 14.07M
Gross Interest Expense 8.22M 3.86M 8.58M 13.87M 14.07M
Interest Capitalized 0 0 0 0 0
Pretax Income 60.74M 78.36M 59.3M 82.77M 192.57M
Income Tax 9.91M 13.9M 6.5M 15.67M 52.46M
Income Tax - Current Domestic 663,220 (447,561) (847,124) 2.97M 0
Income Tax - Current Foreign 12.81M 17.51M 9.69M 19.27M 78.69M
Income Tax - Deferred Domestic (3.56M) (3.17M) (2.35M) (6.57M) (26.23M)
Income Tax - Deferred Foreign 0 - - - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 (726,106) 562,922 (1.92M)
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 50.83M 64.46M 52.07M 67.66M 138.19M
Minority Interest Expense 1.05M 439,141 2.1M 4.35M 2.56M
Net Income 49.78M 64.02M 49.97M 63.31M 135.63M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 49.78M 64.02M 49.97M 63.31M 135.63M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 49.78M 64.02M 49.97M 63.31M 135.63M
EPS (Basic) 0.26 0.33 0.26 0.32 0.69
Basic Shares Outstanding 189.76M 192.3M 194.14M 196.35M 197M
EPS (Diluted) 0.26 0.33 0.25 0.32 0.69
Diluted Shares Outstanding 193.73M 196.86M 197.77M 198.3M 198M
EBITDA 88.83M 106.92M 109.7M 148.37M 290.45M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Hikma Pharmaceuticals PLC ADS
Fiscal year is January-December. All values GBP millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 408.11M 473.43M 572.67M 699.69M 873.27M
Cost of Goods Sold (COGS) incl. D&A 212.89M 241.98M 324.94M 383.45M 384.49M
COGS excluding D&A 191M 217.08M 295.62M 346.6M 342.91M
Depreciation & Amortization Expense 21.88M 24.89M 29.32M 36.85M 41.58M
Depreciation 16.15M 18.84M 22.24M 26.73M 30.07M
Amortization of Intangibles 5.73M 6.05M 7.08M 10.12M 11.52M
Gross Income 195.22M 231.45M 247.72M 316.24M 488.77M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 116.37M 134.29M 154.51M 187.4M 218.8M
Research & Development 10.79M 15.29M 19.47M 21.47M 19.83M
Other SG&A 105.58M 119M 135.03M 165.93M 198.96M
Other Operating Expense 11.91M 15.13M 12.84M 17.32M 21.11M
Unusual Expense 0 342,633 11.31M 9.08M 39.66M
EBIT after Unusual Expense 0 (342,633) (11.31M) (9.08M) (39.66M)
Non Operating Income/Expense 1.68M 309,601 (1.48M) (6.61M) (3.84M)
Non-Operating Interest Income 329,367 224,104 291,940 798,946 1.28M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 8.22M 3.86M 8.58M 13.87M 14.07M
Gross Interest Expense 8.22M 3.86M 8.58M 13.87M 14.07M
Interest Capitalized 0 0 0 0 0
Pretax Income 60.74M 78.36M 59.3M 82.77M 192.57M
Income Tax 9.91M 13.9M 6.5M 15.67M 52.46M
Income Tax - Current Domestic 663,220 (447,561) (847,124) 2.97M 0
Income Tax - Current Foreign 12.81M 17.51M 9.69M 19.27M 78.69M
Income Tax - Deferred Domestic (3.56M) (3.17M) (2.35M) (6.57M) (26.23M)
Income Tax - Deferred Foreign 0 - - - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 (726,106) 562,922 (1.92M)
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 50.83M 64.46M 52.07M 67.66M 138.19M
Minority Interest Expense 1.05M 439,141 2.1M 4.35M 2.56M
Net Income 49.78M 64.02M 49.97M 63.31M 135.63M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 49.78M 64.02M 49.97M 63.31M 135.63M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 49.78M 64.02M 49.97M 63.31M 135.63M
EPS (Basic) 0.26 0.33 0.26 0.32 0.69
Basic Shares Outstanding 189.76M 192.3M 194.14M 196.35M 197M
EPS (Diluted) 0.26 0.33 0.25 0.32 0.69
Diluted Shares Outstanding 193.73M 196.86M 197.77M 198.3M 198M
EBITDA 88.83M 106.92M 109.7M 148.37M 290.45M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)